Looks like people are already warming up for tomorrow's Open Access Day. In the Guardian, Richard Smith pens a column on Springer's acquisition of BioMed Central, which he says may turn out to be a pivotal moment in the history of scientific publishing. "I'm no seer, but it became obvious to me in the mid-90s, when ... I was the chief executive of the BMJ Publishing Group, that the transition to open access would have to happen," he writes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.